Metoprolol Succinate Tablet, Extended Release
Product Images NDC 62207-131

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 62207-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metoprolol-100mg-30s (Metoprolol 100mg 30s)

Metoprolol-100mg-30s (Metoprolol 100mg 30s)
Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg. The label states the package contains 30 tablets, each with 95 mg metoprolol succinate equivalent to 100 mg metoprolol tartrate, USP. It is manufactured by Granules India Limited, Hyderabad, India, and distributed by Granules Pharmaceuticals Inc., Chantilly, VA. Storage instructions and a warning to keep out of reach of children are included. The label includes the NDC number 62207-131-54 and barcode.*
FDA Label Image

Metoprolol-200mg-30s (Metoprolol 200mg 30s)

Metoprolol-200mg-30s (Metoprolol 200mg 30s)
Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg, oral dosage form in a package of 30 tablets. Manufactured by Granules India Limited, Hyderabad, India, and labeled for Granules Pharmaceuticals Inc., Chantilly, VA. The label shows NDC 62207-132-54 and includes storage instructions and a warning to keep out of reach of children.*
FDA Label Image

Metoprolol-25mg-30s (Metoprolol 25mg 30s)

Metoprolol-25mg-30s (Metoprolol 25mg 30s)
Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength, packaged in a bottle containing 30 tablets. The label specifies each tablet contains 23.75 mg metoprolol succinate, equivalent to 25 mg metoprolol tartrate. Manufactured by Granules India Limited and labeled for Granules Pharmaceuticals Inc. The label includes storage instructions, a barcode, and space for lot and expiration dates.*
FDA Label Image

Metoprolol-50mg-30s (Metoprolol 50mg 30s)

Metoprolol-50mg-30s (Metoprolol 50mg 30s)
Label for Metoprolol Succinate Extended-Release Tablets, USP, 50 mg strength. The label indicates a package of 30 tablets, manufactured by Granules India Limited and for Granules Pharmaceuticals Inc. The label includes storage instructions, a barcode, and space for lot and expiration information.*
FDA Label Image

Metoprolol-figure (Metoprolol Figure Jpg)

Metoprolol-figure (Metoprolol Figure Jpg)
A forest plot chart displaying subgroup analyses from the MERIT-HF study, showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geographic location, NYHA class, ejection fraction, etiology, sex, ethnicity, history of myocardial infarction, diabetes status, hypertension, and heart rate.*
FDA Label Image

Metoprolol-structure (Metoprolol Structure Jpg)

Metoprolol-structure (Metoprolol Structure Jpg)
Chemical structure of Metoprolol Succinate, showing its molecular arrangement including aromatic rings and functional groups typical of this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.